
Estxone 500mg Injection
Marketer
Ester Formulations
Salt Composition
Ceftriaxone (500mg)
Overview Estxone 500mg Injection
Cephalosporin antibiotic, Cefix 500mg Injection, combats bacterial infections throughout the body. Its applications span diverse infections: meningitis and pneumonia (affecting the brain and lungs, respectively), as well as ear, urinary tract, skin and soft tissue, bone and joint, bloodstream, and heart infections. Cefix 500mg Injection also serves as a prophylactic against surgical site infections. Administered intravenously (drip) or via intramuscular/intravenous injection by a healthcare professional, the dosage is determined individually by your physician. Consistent, evenly spaced doses, as directed, are crucial; premature cessation may result in infection recurrence or exacerbation. Common side effects include diarrhea, skin rash, altered liver function test results, and variations in blood cell counts (e.g., elevated eosinophils, reduced leukocytes, thrombocytopenia). Transient injection site redness or pain may occur. While generally mild, persistent or bothersome effects warrant medical attention. Prior to treatment, disclose any antibiotic allergies, kidney or liver impairments, and all other medications currently in use to your doctor, as interactions are possible.
Uses of Estxone 500mg Injection
Combating Bacterial Infections
Major Benefits of Estxone 500mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Estxone 500mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Estxone 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Estxone 500mg Injection works:
Estxone 500mg Injection is a bactericidal antibiotic. Its mechanism of action involves disrupting bacterial cell wall synthesis, thereby eliminating the bacteria's protective barrier and causing cell death.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Estxone 500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Estxone, at a 500mg dosage, presents minimal to no documented risk to the fetus during gestation, according to the majority of research.
Breast feedingCAUTION
Administering Estxone 500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Estxone 500mg Injection might reduce awareness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneySAFE IF PRESCRIBED
Estxone 500mg Injection can be administered to patients with kidney disease without altering the dosage. Nevertheless, disclosure of pre-existing renal conditions to the prescribing physician is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Estxone 500mg Injection cautiously; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Estxone 500mg Injection is not advised for individuals with mild or moderate liver dysfunction.
What if you forget to take Estxone 500mg Injection :
Should you forget a scheduled Estxone 500mg Injection, seek your physician's advice.
Facts to Know About Estxone 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Type of Treatment | Anti-infective agents |
